6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Bisphosphonate-related atypical femoral fracture with bone metastasis of breast cancer: case report and review.

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Intravenous bisphosphonates (BPs) have been used to reduce the frequency of skeletal-related events due to bone metastases of several kinds of cancers. Although many studies on BP-related atypical fractures (BRAFs) due to the use of BP for osteoporosis treatment have been reported, few reports on BRAFs arising as a complication of long-term BP use for bone metastasis of cancer are available.

          Related collections

          Author and article information

          Journal
          Anticancer Res.
          Anticancer research
          1791-7530
          0250-7005
          Mar 2014
          : 34
          : 3
          Affiliations
          [1 ] 2-13-22 Miyakojimahondori Miyakojima-ku, Osaka, 534-0021 Japan. kh_ocg@yahoo.co.jp.
          Article
          34/3/1245
          24596367
          c11db51a-88b0-4f85-afa1-5477ea5aa03f
          History

          Zoledronate,atypical femoral fracture,bone metastasis,breast cancer

          Comments

          Comment on this article